Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
By Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini
• Context: Over centuries, the management of deep vein thrombosis (DVT) has evolved from empirical bloodletting to the precision of direct oral anticoagulants (DOACs).
• Overview: This historical review traces how DOACs revolutionized therapy—simplifying treatment, redefining duration and intensity, and reshaping clinical guidelines.
• Reflection: Despite progress, the “philosopher’s stone” of anticoagulation—perfect safety without loss of efficacy—remains elusive. Novel FXI/XIa inhibitors and AI-guided individualized therapy may herald the next transformation in DVT care.”
Read the full article in JTH.
Article: The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Authors: Jean Philippe Galanaud, Jean Pierre Laroch, Marc Righini
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment
-
Mar 19, 2026, 16:49Marilena Vrana: Access, Resilience, and Policy Priorities Ahead of IPPC2026
-
Mar 19, 2026, 16:46Connie Montgomery: Celebrating Heroes of the Bleeding Disorders Community
-
Mar 19, 2026, 16:44Anita Brikman: Advancing Plasma Availability and Access to Plasma-Derived Therapies in India
-
Mar 19, 2026, 16:41Sinju Thomas: Early Initiation and Collaboration are Critical in Stem Cell Collection for Haemoglobinopathies